MENU
PDSB
AS OF
Jan 17 closing price
Price
$1.45
Change
+$0.02 (+1.40%)
Capitalization
54.24M
68 days until earnings call
PDSB
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.45
Change
+$0.02 (+1.40%)
Capitalization
54.24M
PDSB PDS Biotechnology Corp Chart, History Price & Graph
a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
PDSB and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with RXRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then RXRX could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To PDSB | 1D Price Change % | ||
|---|---|---|---|---|
| PDSB | 100% | +1.40% | ||
| RXRX - PDSB | 46% Loosely correlated | +2.03% | ||
| PRME - PDSB | 43% Loosely correlated | +0.70% | ||
| BPMC - PDSB | 42% Loosely correlated | +5.87% | ||
| NTLA - PDSB | 41% Loosely correlated | +0.85% | ||
| TRDA - PDSB | 40% Loosely correlated | +1.20% | ||
More | ||||